XML 34 R20.htm IDEA: XBRL DOCUMENT v3.20.4
FINANCIAL INSTRUMENTS
12 Months Ended
Dec. 31, 2020
Investments, All Other Investments [Abstract]  
FINANCIAL INSTRUMENTS

NOTE 13  -  FINANCIAL INSTRUMENTS

A.Hedging Activities

The Company enters into forward contracts, and currency options to hedge its balance sheet exposure as well as certain future cash flows in connection with certain operating expenses (mainly payroll expense) and forecast transactions which are expected to be denominated mainly in New Israeli Shekel ("NIS"). The Company is exposed to losses in the event of non-performance by counterparties to financial instruments; however, as the counterparties are major Israeli banks, credit risk is considered immaterial. The Company does not hold or issue derivatives for trading purposes. The notional amounts of the hedging instruments as of December 31, 2020 and December 31, 2019 were $17,675, and $16,174 respectively. The terms of all of these currency derivatives are less than one year.

B.Derivative Instruments

The fair value of derivative contracts as of December 31, 2019 and December 31, 2018 was as follows:

 

 

Derivative Assets

Reported in

Other Current Assets

 

 

Derivative Liabilities

Reported in

Other Current Liabilities

 

 

 

December 31,

 

 

December 31,

 

 

 

2 0 2 0

 

 

2 0 1 9

 

 

2 0 2 0

 

 

2 0 1 9

 

Derivatives designated as hedging instruments in cash flow hedge

 

644

 

 

$

68

 

 

 $

-

 

 

$

-

 

The impact of derivative instrument on total operating expenses in the year ended December 31, 2020, 2019 and 2018 was:

 

 

Year ended December 31,

 

 

 

2 0 2 0

 

 

2 0 1 9

 

 

2 0 1 8

 

 

 

 

 

 

 

 

 

 

 

Loss (gain) on derivative instruments

 

 $

796

 

 

$

33

 

 

$

(189

)